Spring til hovednavigation Spring til søgning Spring til hovedindhold

Prognostic impact of clinician-based interpretation of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphoma

  • Karen J Mylam
  • , Tarec Christoffer El-Galaly
  • , Martin Hutchings
  • , Peter Brown
  • , Bodil Himmelstrup
  • , Oke Gerke
  • , Dorte Gillstrøm
  • , Ida Blok Sillesen
  • , Lars Munksgaard
  • , Bjarne B Pedersen
  • , Ilse Christiansen
  • , Paw Jensen
  • , Anne Louise Nielsen
  • , Lars M Pedersen
    8 Citationer (Scopus)

    Abstract

    The aim of this study was to evaluate the prognostic value of clinician interpretation of positron emission tomography/computed tomography (PET/CT) reports at mid-therapy, interim PET (I-PET) and after the end of first-line therapy (E-PET) in patients with diffuse large B-cell lymphoma (DLBCL). Four hundred and thirty patients were enrolled in this study comprising a total of 617 PET reports. Each report was evaluated by three expert hematologists randomly selected from a panel of nine. Reports were labeled positive or negative if all three interpreters agreed. All others were considered indeterminate. Indeterminate reports accounted for 59% of I-PET and 49% of E-PET reports. Two-year overall survival (OS) for patients with a positive, indeterminate and negative I-PET was 58%, 87% and 89% (p
    OriginalsprogEngelsk
    TidsskriftLeukemia and Lymphoma
    Vol/bind55
    Udgave nummer7
    Sider (fra-til)1563-69
    ISSN1042-8194
    DOI
    StatusUdgivet - 2014

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Prognostic impact of clinician-based interpretation of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphoma'. Sammen danner de et unikt fingeraftryk.

    Citationsformater